Treatment (T) | Challenge (C) | BW, g | BWG, g | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
1 d | 7 d | 14 d | 21 d | 30 d | 1–7 d | 7–14 d | 14–21 d | 21–30 d | 1–30 d | ||
CON | NE- | 40 | 185 | 446 | 867 | 1,714 | 145 | 261 | 421 | 847 | 1,674 |
STB | NE- | 40 | 187 | 451 | 897 | 1,780 | 147 | 264 | 446 | 883 | 1,740 |
CB | NE- | 40 | 189 | 455 | 900 | 1,798 | 149 | 265 | 446 | 897 | 1,757 |
CON | NE +  | 40 | 184 | 445 | 779 | 1,583 | 144 | 261 | 333 | 805 | 1,543 |
STB | NE +  | 40 | 188 | 451 | 805 | 1,678 | 148 | 263 | 354 | 873 | 1,638 |
CB | NE +  | 40 | 189 | 453 | 819 | 1,670 | 148 | 264 | 366 | 851 | 1,629 |
SEM2 | Â | Â | 2.5 | 4.8 | 11.8 | 32.6 | 2.5 | 4.8 | 11.4 | 32.6 | 32.6 |
Treatment | |||||||||||
 CON |  | 40 | 184 | 445 | 823b | 1,648b | 144 | 261 | 377b | 826 | 1,608b |
 STB |  | 40 | 188 | 451 | 851a | 1,729a | 147 | 263 | 400a | 878 | 1,689a |
 CB |  | 40 | 189 | 454 | 860a | 1,734a | 149 | 265 | 406a | 874 | 1,693a |
 | Challenge |  |  |  |  |  |  |  |  |  |  |
 |   NE- | 40 | 187 | 450 | 888a | 1,764a | 147 | 263 | 438a | 876 | 1,724a |
 |   NE+  | 40 | 187 | 449 | 801b | 1,644b | 147 | 263 | 351b | 843 | 1,603b |
P-value | |||||||||||
 T |  | - | 0.19 | 0.22 | 0.007 | 0.02 | 0.19 | 0.72 | 0.034 | 0.21 | 0.02 |
 C |  | - | 0.86 | 0.81 |  < 0.001 | < 0.001 | 0.86 | 0.87 |  < 0.001 | 0.22 |  < 0.001 |
 T × C |  | - | 0.92 | 0.97 | 0.89 | 0.89 | 0.92 | 0.98 | 0.84 | 0.83 | 0.89 |